Higher antioxidant defences in plasma and low density lipoproteins from rugby players

European Journal of Clinical Investigation

Volumn 32, Issue 11, 2002, Pages 818-825

  Evelson, P ^a   Gambino, G ^a   Travacio, M ^a   Jaita, G ^a   Verona, J ^a   Maroncelli, C ^b   Wikinski, R ^a   Llesuy, S ^a   Brites, F ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL MILITAR CENTRAL   (Argentina)

Author keywords

Antioxidants; Atherosclerosis; Exercise; Lipoproteins; Oxidative stress; Paraoxonase

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DENSITY; EXERCISE; HUMAN; IN VITRO STUDY; NORMAL HUMAN; OXIDATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTECTION; RUGBY; SITTING; TRAINING;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; CARBOXYLIC ESTER HYDROLASES; CASE-CONTROL STUDIES; CATALASE; CHOLESTEROL, HDL; FOOTBALL; HUMANS; LIPOPROTEINS, LDL; MALE; PHYSICAL ENDURANCE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 0036435550     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01057.x     Document Type: Article

References (50)

1. Salonen JT, Pusha P, Tuomilento J. Physical activity and risk of myocardial infarction, cerebral stroke and death. Am J Epidemiol 1982;115:526-37.
2. Kannel WB, Belanger A, D'Agostino R, Israel I. Physical activity and physical demand on the job and risk of cardiovascular disease and death. The Framingham Study Am Heart J 1986;112:820-5.
3. Durstine JL, Haskell WL. Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 1994;22:477-521.
4. Fentem PH. Benefits of exercise in health and disease. Br Med J 1994;308:1291-5.
5. Weintraub MS, Rosen Y, Otto R, Eisenberg S, Breslow JL. Physical exercise conditioning in the absence of weight loss reduces fasting and post-prandial triglyceride rich lipoprotein levels. Circulation 1989;79:1007-14.
6. Nakamura N, Uzawa H, Haeda H, Inomoto T. Physical fitness, its contribution to serum high density lipoprotein. Atherosclerosis 1983;48:173-81.
7. Tsopanakis C, Kotsarellis D, Tsopanakis A. Plasma lecithin: Cholesterol acyltransferase in elite athletes from selected sports. Eur J Appl Physiol 1988;58:262-5.
8. Brites FD, Evelson PA, García Christiansen M, Nicol MF, Basílico MJ, Wikinski RW et al. Soccer players under regular training show oxidative stress but an improved plasma antioxidant status. Clin Sci 1999;96:381-5.
9. Sies H. Oxidative stress: Introductory remarks. In: Sies H, ed. Oxidative Stress. San Diego: Academic Press;1985.pp. 1-7.
10. Kanter MM. Free radicals, exercise and antioxidant supplementation. Proc Nutr Soc 1998;57:9-13.
11. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BNJ. Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: A possible peroxidative role for paraoxonase. J Clin Invest 1998;101:1581-90.
12. Nevin DN, Zambon A, Furlong CE, Richter RJ, Humbert R et al. Paraoxonase genotypes, lipoprotein lipase activity, and HDL. Arterioscler Thromb Vasc Biol 1996;16:1243-9.
13. Parthasarathy S, Barnett J, Fong LG. High density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990;1044:275-83.
14. Glomset JA. The plasma lecithin: Cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67.
15. Steinberg S, Parthasarathy D, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989;4:915-24.
16. Yla Hertualla S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
17. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992;13:341-90.
18. Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. Meth Enzymol 1986;128:155-70.
19. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 1968;9:693-700.
20. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
21. Assmann G, Jabs HU, Kohnert U, Nolte W, Schriewer H. LDL (low-density-lipoprotein) cholesterol determination in blood serum following precipitation of LDL with poly (vinil sulphate). Clin Chim Acta 1984;140:77-83.
22. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-8.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
24. Lissi E, Pascual C, Del Castillo M. Luminol luminescence induced by 2,2′-azo-bis-amidinopropane thermolysis. Free Rad Res Comm 1992;17:299-312.
25. Kyaw A. A simple colorimetric method for ascorbic acid determination in blood plasma. Clin Chim Acta 1978;86:153-7.
26. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem 1986;157:106-16.
27. Misra H, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
28. Chance B. Special methods: catalase. In: Glick R, ed. Methods of Biochemical Analysis. New York: Interscience 1954. pp. 408-24.
29. Furlong CE, Richter RJ, Seidel SL, Costa LG, Motulsky AG. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of clorpyrifos and parathion by plasma paraoxonase/arylesterase. Anal Biochem 1989;180:242-7.
30. Yagi K. A simple fluorometric assay for lipoperoxides in blood plasma. Biochem Med 1976;15:212-6.
31. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990;132:612-28.
32. Rifai N, Dufour R, Cooper GR. Preanalytical variation in lipid, lipoprotein, and apolipoprotein testing. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of Lipoprotein Testing. Washington: AACC Press; 1997. pp. 75-97.
33. Thompson PD, Cullinane EM, Sady SP, Flynn MM, Chenevert CB, Herbert PN. High density lipoprotein metabolism in endurance athletes and sedentary men. Circulation 1991;84:140-52.
34. Cullinane EM, Siconolfi S, Saritelli A, Thompson PD. Acute decrease in serum triglycerides with exercise: Is there threshold for an exercise effect? Metabolism 1982;31:844-7.
35. Sánchez-Quesada JL, Ortega H, Payés-Romero A, Serrat-Serrat J, González-Sastre F, Lasunción MA, et al. LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects. Atherosclerosis 1997;132:207-13.
36. Kanter MM. Free radicals exercise and antioxidant supplementation. Int J Sport Nutr 1994;4:205-20.
37. Sen C. Oxidants and antioxidants in exercise. J Appl Physiol 1993;79:675-83.
38. Evelson P, Travacio M, Repetto M, Escobar M, Llesuy S, Lissi E. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 2001;2:261-6.
39. Dekkers JC, van Doornen LJP, Kemper HCG. The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Med 1996;21:213-38.
40. Maxwell SRJ, Jakeman P, Thomason H. Changes in plasma antioxidant status during eccentric exercise and the effect of vitamin supplementation. Free Rad Res Comm 1993;19:191-201.
41. Jenkins RR. Exercise, oxidative stress, and antioxidants: A review. Int J Sport Nutr 1993;3:356-75.
42. Sjodin B, Hellsten-Westing Y, Apple FS. Biochemical mechanisms for oxygen free radical formation during exercise. Sports Med 1990;10:236-54.
43. Diplock A. The role of vitamin E in biological membranes. In: Biology of Vitamin E. London: Pitman Books;1983.pp. 45-55.
44. Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000;28:141-64.
45. Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogeneous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol 1997;17:786-96.
46. Brigelius-Flohé R, Traber MG, Vitamin E. function and metabolism. FASEB J 1999;13:1145-55.
47. Shern-Brewer R, Santanam N, Wetzstein C, White-Welkley J, Parthasarathy S. Exercise and cardiovascular disease. A new perspective. Arterioscler Thromb Vasc Biol 1998;18:1181-7.
48. Ginsburg GS, O'Toole M, Rimm E, Douglas PS, Rifai N. Gender differences in exercise-induced changes in sex hormone levels and lipid peroxidation in athletes participating in the Hawaii Ironman triathlon. Clin Chim Acta 2001;305:131-9.
49. Mackness M, Abbot C, Arrol S, Durrington P. The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low density lipoprotein oxidation. Biochem J 1993;294:829-34.
50. Aviram M. Does paraoxonase play a role in susceptibility to cardiovascular disease? Mol Med Today 1999;5:381-6.